The second activity of the NBA's program is to improve the performance of the blood sector, and to manage risks associated with the supply and administration of blood products.
The deliverables and key performance indicators for this function, and our performance, are described below:
| Qualitative deliverables | 2011-12 reference point or target | Results | |
|---|---|---|---|
| Required reserve levels of all products are in place | Review completion of appropriate reserve levels for fractionated and recombinant products and results are implemented in accordance with agreed contractual obligations | In-country reserve and minimum product inventory levels have been established and updated for all relevant imported and domestic products under relevant contracts | |
| Quantitative deliverable | 2011-12 budget | 2011-12 actual | |
| Percentage of recommendations from the Administrative Review of the National Blood Arrangements, for which the NBA had responsibility, completed within timeframes | >=95% | 96% Work on the outstanding recommendation is ongoing together with JBC and is expected to be completed during 2012-13. | |
| Percentage of requesting hospitals provided with access to BloodNet within agreed timeframe | 95% | 100% (see pages 62-63) |
| Quantitative deliverable | 2011-12 reference point or target | Results | |
|---|---|---|---|
| Management and support of BloodNet | High level of satisfaction of all funding jurisdictions with NBA's planning, management and coordination of blood supply. Satisfaction is assessed through survey of Jurisdictional Blood Committee members and hospitals that have implemented BloodNet | 78% of jurisdictions were very satisfied with the NBA's management approach and support for users during the implementation of BloodNet. The remaining 22% were not satisfied, citing some communication issues and
lack of access to data. 78% of jurisdictions were very satisfied with the NBA's management approach and support for users during the implementation of BloodNet. The remaining 22% were not satisfied, citing some communication issues and lack of access to data. A high level of satisfaction with BloodNet was expressed by hospitals that have implemented BloodNet, rating as good or above: - email and phone support- 85%+ - user materials-80%+ - functionality-85%+ (see pages 62-63) |
|
| Management of the National Blood Supply Contingency Plan | High level of satisfaction of all funding jurisdictions with NBA's management and implementation assessed through survey of Jurisdictional Blood Committee members | 78% of jurisdictions were satisfied with the NBA's management, including with the advice provided during the Albumex recall, commenting on the improvements made after each activation of the NBSCP. 22% were not satisfied, pointing to timing, coordination and communication issues, some
of which were not solely the NBA's responsibility. (see page 80) |
|
| Qualitative indicator | 2011-12 budget | 2011-12 actusl | |
| Percentage of hospitals using BloodNet | 60% | 75% | |
| Percentage of clotting factor usage captured in the Australian Bleeding Disorders Registry | 80% | 81% (see page 65) |
|
| Number of days the National Blood Supply Contingency Plan is activated for plasma and recombinant products | 0 | 41, following notification by CSL Ltd of a potential Albumin shortage due to a product recall. (see page 80) |